Sabra Healthcare REIT (NASDAQ:SBRA) Posts Quarterly Earnings Results, Misses Expectations By $0.05 EPS

Sabra Healthcare REIT (NASDAQ:SBRA) issued its earnings results on Monday. The real estate investment trust reported $0.11 EPS for the quarter, missing the consensus estimate of $0.16 by ($0.05), FiscalAI reports. Sabra Healthcare REIT had a net margin of 7.61% and a return on equity of 2.34%. The firm had revenue of $246.34 million during the quarter, compared to analyst estimates of $236.64 million.

Sabra Healthcare REIT Stock Down 0.1%

SBRA traded down $0.02 during mid-day trading on Monday, reaching $19.72. 3,358,445 shares of the stock were exchanged, compared to its average volume of 2,663,508. Sabra Healthcare REIT has a 1 year low of $17.53 and a 1 year high of $22.77. The company has a debt-to-equity ratio of 0.95, a quick ratio of 3.07 and a current ratio of 3.07. The stock has a market capitalization of $5.04 billion, a PE ratio of 75.85, a price-to-earnings-growth ratio of 1.79 and a beta of 0.63. The company has a 50 day moving average price of $19.87 and a two-hundred day moving average price of $19.96.

Analysts Set New Price Targets

A number of brokerages have commented on SBRA. Weiss Ratings cut Sabra Healthcare REIT from a “hold (c+)” rating to a “hold (c)” rating in a research note on Thursday, October 8th. Truist Financial increased their target price on Sabra Healthcare REIT from $22.00 to $24.00 and gave the stock a “buy” rating in a report on Wednesday, July 22nd. Wells Fargo & Company reduced their price target on shares of Sabra Healthcare REIT from $23.00 to $21.00 and set an “overweight” rating for the company in a research report on Monday, October 19th. Mizuho set a $21.00 price target on shares of Sabra Healthcare REIT in a research note on Monday, August 31st. Finally, UBS Group lowered their price objective on shares of Sabra Healthcare REIT from $21.00 to $20.00 and set a “neutral” rating on the stock in a report on Tuesday, October 13th. Seven research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $21.50.

Insider Buying and Selling at Sabra Healthcare REIT

In other Sabra Healthcare REIT news, CEO Richard Matros sold 200,000 shares of the stock in a transaction dated Tuesday, September 8th. The shares were sold at an average price of $20.83, for a total value of $4,166,000.00. Following the completion of the sale, the chief executive officer owned 1,657,686 shares in the company, valued at approximately $34,529,599.38. This trade represents a 10.77% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.09% of the stock is owned by insiders.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc is a self-managed real estate investment trust that owns and invests in healthcare-related real estate. The company focuses primarily on properties used for skilled nursing and transitional care, senior housing, behavioral health, specialty hospitals and other healthcare services.

Sabra leases properties to healthcare operators and also provides capital through loans, joint ventures and other real estate investments. Its portfolio is designed to support a range of care settings, including facilities serving seniors, patients requiring rehabilitation and individuals receiving behavioral healthcare.

Founded in 2010 and headquartered in Irvine, California, Sabra has expanded through acquisitions, development investments and strategic transactions, including its 2017 combination with Care Capital Properties.